WINDOME BANKING PARTNERS SAS Windome Banking Partners SAS
English French German
Mr. Coste
Menu
  • Our Firm
    • Premium Healthcare Expertise
    • 40 Years of Experience
    • Access to Decision Makers
    • Client First
  • Services
    • M&A Advisory
    • Capital Market Advisory
    • Market Reports
    • Strategic Corporate Consulting
  • Transactions
  • Conferencing & Publications
  • Senior Management
  • Scientific Advisory Board
  • Insights & Publications
  • Careers & Contact

Selected transactions

Region

Filter
Therapeutic AreaRegionDeal TypeNon Pharma
Apply Filters
March 1999

Exclusive Financial Advisor for the issuance of equity instruments (SWORD: Stock Warrant Off-Balance-Sheet R&D vehicle), consisting in the demerger of Central Nervous System assets.

Undisclosed terms.
January 1999

Exclusive Financial Advisor in the acquisition of the Swedish Industrial Gas Corporation AGA.

Swedish Kr. 10bn Total enterprise value.
July 1998

Exclusive Financial Advisor to Tobaccoland GmbH & Co KG, in the combination via merger of their cigarette manufacturing and distribution activities with Austria Tabak.

DEM 4bn Total consideration.
March 1998

Exclusive Financial Advisor to VIAG on the sale of their Chemicals Distribution Kloeckner Chemie to mg Technologies.

DEM 950m Total consideration.
November 1997

Exclusive Financial Advisor in the review of German Targets and the acquisition of a majority equity stake in Schwarz Pharma.

Undisclosed terms.
September 1997

Exclusive Advisor in the divestiture of Bayer’s Enamels And Ceramics Division via a Spin-off into a separate legal entity to Advent International.

DEM 220m Total consideration.
Previous
1 2 3 4
1 2 3 4
Previous

WINDOME BANKING PARTNERS SAS

Resources

  • Our Firm
  • Services
  • Transactions
  • Senior Management
  • News & Insights
  • Careers

Socials

  • Linkedin
  • LinkedIn Mr. Coste
  • Facebook
  • Instagram
  • X @jycoste
  • Contact
@2025 WINDOME BANKING PARTNERS SAS. All rights reserved.
  • Legal and regulatory information
  • Data & Privacy Notice
  • General Business Terms and Conditions